Application and Exploration of Personalized ctDNA-MRD Detection Technology in Predicting the Efficacy of Neoadjuvant Therapy for Rectal Cancer

NCT07393048 · clinicaltrials.gov ↗

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Rectal Cancer (LARC)

Interventions

DIAGNOSTIC_TEST: Personalized ctDNA-MRD Detection

Sponsor

Beijing Friendship Hospital